Total Visits

Views
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study71

Total Visits Per Month

August 2023September 2023October 2023November 2023December 2023January 2024February 2024March 2024April 2024May 2024June 2024
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study11005632442

File Visits

Views
FBargiela_Discontinuation.pdf111

Top country views

Views
United States39
Sweden7
China6
Ireland6
Spain2
United Kingdom2
Argentina1
Canada1
Germany1
France1

Top cities views

Views
Ashburn10
Fairfield7
Dublin6
Cambridge5
Hangzhou5
Menlo Park4
San Diego3
A Coruña2
Boardman2
Mountain View2